Skip to main content
Top
Published in: BMC Ophthalmology 1/2012

Open Access 01-12-2012 | Case report

Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report

Authors: Koji Sugioka, Aya Kodama, Koji Yoshida, Kiyotaka Okada, Masahiko Fukuda, Yoshikazu Shimomura

Published in: BMC Ophthalmology | Issue 1/2012

Login to get access

Abstract

Background

Corneal ulceration leading to perforation is associated with infectious and non-infectious destructive conditions in the cornea. The fibrinolytic (plasminogen/plasmin) system is considered to contribute to tissue remodeling in the wound healing process and it is believed to play an important role in proteolysis and fibrosis. To determine the localization of urokinase-type plasminogen activator (u-PA), u-PA receptor (u-PAR) and α2-antiplasmin (α2AP) in the tissue of a corneal perforation, we investigated immunohistochemical expressions of u-PA, u-PAR, α2AP, CD68, and α-smooth muscle actin (α-SMA) in a patient with corneal perforation that developed from an ulcer of no clear cause.

Case presentation

The patient was a 77-year-old woman who presented with a perforated corneal ulcer in her right eye. The cause of her corneal ulcer was unknown. Double immunohistochemistry was performed for the combinations of u-PA with u-PAR, CD68 or α-SMA and α2AP with CD68 or α-SMA to detect the localization of u-PA and α2AP. u-PA and u-PAR co-localization was seen in the corneal ulceration area. u-PA was mainly observed in CD68-positive cells and in some α-SMA positive cells. On the other hand, α2AP was not expressed in CD68-positive cells, but was expressed in α-SMA positive cells.

Conclusion

We identified expression of the u-PA/u-PAR complex and α2AP in a patient with a corneal ulcer. These two molecules are believed to play a crucial role in inflammatory cell recruitment, ECM synthesis and degradation during corneal wound healing.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fini ME: Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Retin Eye Res. 1999, 18 (4): 529-551. 10.1016/S1350-9462(98)00033-0.CrossRefPubMed Fini ME: Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Retin Eye Res. 1999, 18 (4): 529-551. 10.1016/S1350-9462(98)00033-0.CrossRefPubMed
2.
go back to reference Fini ME, Cook JR, Mohan R: Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res. 1998, 290 (Suppl): S12-23.CrossRefPubMed Fini ME, Cook JR, Mohan R: Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res. 1998, 290 (Suppl): S12-23.CrossRefPubMed
3.
go back to reference Sivak JM, Fini ME: MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res. 2002, 21 (1): 1-14. 10.1016/S1350-9462(01)00015-5.CrossRefPubMed Sivak JM, Fini ME: MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res. 2002, 21 (1): 1-14. 10.1016/S1350-9462(01)00015-5.CrossRefPubMed
4.
go back to reference Blasi F, Carmeliet P: uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol. 2002, 3 (12): 932-943. 10.1038/nrm977.CrossRefPubMed Blasi F, Carmeliet P: uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol. 2002, 3 (12): 932-943. 10.1038/nrm977.CrossRefPubMed
5.
go back to reference Blasi F, Vassalli JD, Dano K: Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J Cell Biol. 1987, 104 (4): 801-804. 10.1083/jcb.104.4.801.CrossRefPubMed Blasi F, Vassalli JD, Dano K: Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J Cell Biol. 1987, 104 (4): 801-804. 10.1083/jcb.104.4.801.CrossRefPubMed
6.
go back to reference Lijnen HR: Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry (Mosc). 2002, 67 (1): 92-98. 10.1023/A:1013908332232.CrossRef Lijnen HR: Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry (Mosc). 2002, 67 (1): 92-98. 10.1023/A:1013908332232.CrossRef
7.
go back to reference Smith HW, Marshall CJ: Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol. 2010, 11 (1): 23-36. 10.1038/nrm2821.CrossRefPubMed Smith HW, Marshall CJ: Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol. 2010, 11 (1): 23-36. 10.1038/nrm2821.CrossRefPubMed
8.
go back to reference Levi M, Roem D, Kamp AM, de Boer JP, Hack CE, ten Cate JW: Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo. Thromb Haemost. 1993, 69 (2): 141-146.PubMed Levi M, Roem D, Kamp AM, de Boer JP, Hack CE, ten Cate JW: Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo. Thromb Haemost. 1993, 69 (2): 141-146.PubMed
9.
go back to reference Saksela O: Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta. 1985, 823 (1): 35-65.PubMed Saksela O: Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta. 1985, 823 (1): 35-65.PubMed
10.
go back to reference Collen D: The plasminogen (fibrinolytic) system. Thromb Haemost. 1999, 82 (2): 259-270.PubMed Collen D: The plasminogen (fibrinolytic) system. Thromb Haemost. 1999, 82 (2): 259-270.PubMed
11.
go back to reference Morimoto K, Mishima H, Nishida T, Otori T: Role of urokinase type plasminogen activator (u-PA) in corneal epithelial migration. Thromb Haemost. 1993, 69 (4): 387-391.PubMed Morimoto K, Mishima H, Nishida T, Otori T: Role of urokinase type plasminogen activator (u-PA) in corneal epithelial migration. Thromb Haemost. 1993, 69 (4): 387-391.PubMed
12.
go back to reference Bernstein AM, Greenberg RS, Taliana L, Masur SK: Urokinase anchors uPAR to the actin cytoskeleton. Invest Ophthalmol Vis Sci. 2004, 45 (9): 2967-2977. 10.1167/iovs.04-0030.CrossRefPubMed Bernstein AM, Greenberg RS, Taliana L, Masur SK: Urokinase anchors uPAR to the actin cytoskeleton. Invest Ophthalmol Vis Sci. 2004, 45 (9): 2967-2977. 10.1167/iovs.04-0030.CrossRefPubMed
13.
go back to reference Tkachuk VA, Plekhanova OS, Parfyonova YV: Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator. Can J Physiol Pharmacol. 2009, 87 (4): 231-251. 10.1139/Y08-113.CrossRefPubMed Tkachuk VA, Plekhanova OS, Parfyonova YV: Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator. Can J Physiol Pharmacol. 2009, 87 (4): 231-251. 10.1139/Y08-113.CrossRefPubMed
14.
go back to reference Bernstein AM, Twining SS, Warejcka DJ, Tall E, Masur SK: Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation. Mol Biol Cell. 2007, 18 (7): 2716-2727. 10.1091/mbc.E06-10-0912.CrossRefPubMedPubMedCentral Bernstein AM, Twining SS, Warejcka DJ, Tall E, Masur SK: Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation. Mol Biol Cell. 2007, 18 (7): 2716-2727. 10.1091/mbc.E06-10-0912.CrossRefPubMedPubMedCentral
15.
go back to reference Ayala A, Warejecka DJ, Vaughan KA, Twining SS, Yue BY: The fibrinolysis inhibitor alpha2-antiplasmin in the human cornea. Curr Eye Res. 2005, 30 (12): 1097-1103. 10.1080/02713680500403046.CrossRefPubMed Ayala A, Warejecka DJ, Vaughan KA, Twining SS, Yue BY: The fibrinolysis inhibitor alpha2-antiplasmin in the human cornea. Curr Eye Res. 2005, 30 (12): 1097-1103. 10.1080/02713680500403046.CrossRefPubMed
16.
go back to reference Jester JV, Ho-Chang J: Modulation of cultured corneal keratocyte phenotype by growth factors/cytokines control in vitro contractility and extracellular matrix contraction. Exp Eye Res. 2003, 77 (5): 581-592. 10.1016/S0014-4835(03)00188-X.CrossRefPubMed Jester JV, Ho-Chang J: Modulation of cultured corneal keratocyte phenotype by growth factors/cytokines control in vitro contractility and extracellular matrix contraction. Exp Eye Res. 2003, 77 (5): 581-592. 10.1016/S0014-4835(03)00188-X.CrossRefPubMed
17.
go back to reference Kurosaka H, Kurosaka D, Kato K, Mashima Y, Tanaka Y: Transforming growth factor-beta 1 promotes contraction of collagen gel by bovine corneal fibroblasts through differentiation of myofibroblasts. Invest Ophthalmol Vis Sci. 1998, 39 (5): 699-704.PubMed Kurosaka H, Kurosaka D, Kato K, Mashima Y, Tanaka Y: Transforming growth factor-beta 1 promotes contraction of collagen gel by bovine corneal fibroblasts through differentiation of myofibroblasts. Invest Ophthalmol Vis Sci. 1998, 39 (5): 699-704.PubMed
18.
go back to reference Kanno Y, Kuroki A, Okada K, Tomogane K, Ueshima S, Matsuo O, Matsuno H: Alpha2-antiplasmin is involved in the production of transforming growth factor beta1 and fibrosis. J Thromb Haemost. 2007, 5 (11): 2266-2273. 10.1111/j.1538-7836.2007.02745.x.CrossRefPubMed Kanno Y, Kuroki A, Okada K, Tomogane K, Ueshima S, Matsuo O, Matsuno H: Alpha2-antiplasmin is involved in the production of transforming growth factor beta1 and fibrosis. J Thromb Haemost. 2007, 5 (11): 2266-2273. 10.1111/j.1538-7836.2007.02745.x.CrossRefPubMed
Metadata
Title
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Authors
Koji Sugioka
Aya Kodama
Koji Yoshida
Kiyotaka Okada
Masahiko Fukuda
Yoshikazu Shimomura
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2012
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/1471-2415-12-60

Other articles of this Issue 1/2012

BMC Ophthalmology 1/2012 Go to the issue